首页> 外文期刊>Cell biochemistry and biophysics >How do drug-induced topoisomerase I-DNA lesions signal to the molecular interaction network that regulates cell cycle checkpoints, DNA replication, and DNA repair?
【24h】

How do drug-induced topoisomerase I-DNA lesions signal to the molecular interaction network that regulates cell cycle checkpoints, DNA replication, and DNA repair?

机译:药物诱导的拓扑异构酶I-DNA损伤如何向调节细胞周期检查点,DNA复制和DNA修复的分子相互作用网络发出信号?

获取原文
获取原文并翻译 | 示例
           

摘要

Recent results suggest that potentially lethal DNA lesions may result when replication forks encounter trapped topoisomerase-DNA complexes or some other types of DNA damage. Such events produce what are called replication-encounter lesions. These lesions have the characteristic that they may allow single stranded DNA-associated replication protein A (RPA) to become juxtaposed to dsDNA end-associated DNA-protein kinase. Our results suggest that DNA-protein kinases may then hyperphosphorylate the RPA2 subunit. We discuss a possible pathway by which hyperphosphorylation of RPA2 could lead to the release of active p53. This could constitute a pathway for signaling the presence of replication-encounter lesions to the p53-dependent cell cycle arrest and/or apoptosis initiator systems.
机译:最近的结果表明,当复制叉遇到捕获的拓扑异构酶-DNA复合物或某些其他类型的DNA损伤时,可能导致潜在的致命DNA损伤。此类事件会产生所谓的复制遭遇损伤。这些病变的特征在于它们可以允许单链DNA相关复制蛋白A(RPA)与dsDNA末端相关DNA蛋白激酶并列。我们的结果表明,DNA-蛋白激酶可能会使RPA2亚基过度磷酸化。我们讨论了RPA2过度磷酸化可能导致活性p53释放的可能途径。这可能构成了向p53依赖的细胞周期停滞和/或凋亡引发系统发信号告知复制遇到的损伤的途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号